Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Schindler EAD

56 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Headache / Migraine 26 Safety 24 Depression 15 Adverse Events 15 Clinical Trial 15 Receptor Pharmacology 14 Mechanism of Action 12 Review Article 12 Chronic Pain 11 Anxiety 10 Observational Study 8 Healthcare Workers 7

Journals

ClinicalTrials.gov 8 Headache 6 medRxiv 2 Journal of Psychedelic Studies 2 Cureus 2 Current pain and headache reports 2 Drug and alcohol dependence 1 The British Journal of Psychiatry 1

Publication history

Prospective real-world evidence of mental health outcomes following supervised psilocybin services within the Oregon state-regulated modelmedRxiv · 2026-08-17 Real-world use, safety, and mental health efficacy of regulated psilocybin services in Oregon and ColoradomedRxiv · 2026-08-12 Mystery shopper assessments of cannabis retailer practices and regulatory compliance in five U.S. states, 2025.Drug and alcohol dependence · 2026-08-01 Psilocybin therapy for adult females with anorexia nervosa: pilot studyThe British Journal of Psychiatry · 2026-07-08 Psychedelic Use, Microdosing, Motives, and Information and Product Sources Among Young Adults in the United States.Journal of psychoactive drugs · 2026-06-19 Effects of psilocybin on sleep quality and brain microstructure in chronic cluster headacheJournal of Psychopharmacology · 2026-05-29 Ancient Wisdom, Modern Questions: Western and Orthodox Christianity Engage Psychedelic SpiritualityReligions · 2026-05-18 From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-10 A128-Channel Wireless Wearable Myolink (W2 Myolink): Functional Characteristics and Multidisciplinary ExperimentsResearch Square · 2026-04-28 Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial.Headache · 2026-04-01 Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping reviewJournal of Psychedelic Studies · 2026-03-09 Pilot study of psilocybin in patients with post-treatment lyme diseaseScientific Reports · 2026-02-25 Patient perspectives on research gaps in cluster headache.Headache · 2026-02-01 5 Years of bipolar disorder conversations on Reddit: Methods, key topics and future directions.PloS one · 2026-01-01 Qualitative insights into psilocybin and LSD experiences: Enhanced connection and emotion processing reported by Spanish-speaking survey respondentsPsychedelics · 2025-11-15 Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.Comprehensive psychiatry · 2025-10-01 Five-year outcomes of psilocybin-assisted therapy for Major Depressive DisorderJournal of Psychedelic Studies · 2025-09-04 Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers: a Randomized Controlled TrialClinicalTrials.gov · 2025-09-02 Efficient Acyloxymethylation of Psilocin and Other Tryptamines Yielding ACOM Prodrugs for Psychedelic-Assisted TherapyArchiv der Pharmazie · 2025-07-01 Ergotamine enhances circadian amplitude and diurnally mitigates nitroglycerin-induced mechanical hypersensitivity.The journal of headache and pain · 2025-05-23 Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01 Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01 Will Psychedelics Propel Your Career? Exploring the Potential Impact of Psychedelics on Work, Productivity and Well-BeingHuman capital leadership. · 2024-11-01 Plain Language Summary Publication: Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: Results from an open-label phase Ib ascending dose studyHeadache The Journal of Head and Face Pain · 2024-10-09 Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry methodJournal of Chromatography A · 2024-08-01 Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial.Journal of the neurological sciences · 2024-05-15 Repeat Dosing of Psilocybin in Headache DisordersClinicalTrials.gov · 2024-02-09 Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping ReviewbioRxiv · 2024-01-05 CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity.Headache · 2024-01-01 Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study.Headache · 2024-01-01 Safety and Efficacy of Psilocybin for the Treatment of Headache DisordersClinicalTrials.gov · 2023-12-15 Studying classic psychedelics for the management of headache disorders: Considerations for Veterans.Journal of military, veteran and family health · 2023-12-01 Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study IIClinicalTrials.gov · 2023-10-12 Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study IClinicalTrials.gov · 2023-10-12 The Potential of Psychedelics for the Treatment of Episodic Migraine.Current pain and headache reports · 2023-09-01 Evaluation of the Acceptability, Safety, Feasibility, and Efficacy of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military VeteransClinicalTrials.gov · 2023-05-25 Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up resultsNeuroscience Applied · 2023-01-01 Case report: Psychedelic-induced seizures captured by intracranial electrocorticography.Frontiers in neurology · 2023-01-01 Adapting psychedelic medicine for headache and chronic pain disorders.Expert review of neurotherapeutics · 2023-01-01 Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double-blind, placebo-controlled trial.Headache · 2022-11-01 An Exploratory Open-Label, Phase 1b, Ascending Dose Study to Evaluate the Effects of Oral 3-[2-(Dimethylamino)Ethyl]-1h-indol-4-yl Dihydrogen Phosphate (Psilocybin, BPL-PSILO) on Cognition in Patients With Chronic Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)ClinicalTrials.gov · 2022-10-12 Psychedelics as preventive treatment in headache and chronic pain disorders.Neuropharmacology · 2022-09-01 Prophylactic Effects of Psilocybin on Chronic Cluster Headache: an Open-label Clinical Trial and Neuroimaging StudyClinicalTrials.gov · 2022-08-10 Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies.Current pain and headache reports · 2022-08-01 Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain.Journal of fungi (Basel, Switzerland) · 2022-03-11 Hallucinogen chemistry guides antidepressant drug discoveryC&EN Global Enterprise · 2022-02-06 Psychedelics in the Treatment of Headache and Chronic Pain Disorders.Current topics in behavioral neurosciences · 2022-01-01 P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot studyEuropean Neuropsychopharmacology · 2021-12-01 Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.Neurotherapeutics: the journal of the American Society for Experimental NeuroTherapeutics · 2021-01-01 People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences.Drugs (Abingdon, England) · 2021-01-01 Study Protocol for "Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study".Frontiers in psychiatry · 2021-01-01 Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.Frontiers in pharmacology · 2021-01-01 Opening Doors of Perception: Psychedelic Drugs and End-of-Life CareJNCI Journal of the National Cancer Institute · 2012-10-25 Alternative headache treatments: nutraceuticals, behavioral and physical treatments.Headache · 2011-03-01 The action of tryptamine on the dog spinal cord and its relationship to the agonistic actions of LSD-like psychotogens.Psychopharmacologia · 1969-12-30 Time contraction and psychomotor performance produced by "Psilocybin".Nature · 1966-01-22

Author directory